UNSPSC 51385802: Isoxicam

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51385802

Definition

This classification denotes a nonsteroidal antiinflammatory drug, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8XU734C4NG. European Medicines Agency schedules Isoxicam in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08344MIG. Isoxicam generally arises in the molecular formula C14H13N3O5S.

Read the full definition

The term ISOXICAM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, no. 10 1974, list 14.) ISOXICAM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule isoxicam under HS 29349990 and SITC 51579. As of Q4 2014, ISOXICAM remains the US FDA Preferred Term for this commodity. Isoxicam bears US NLM identifiers UMLS ID C0064104 and NCI Concept Code C80558. SMILES: S1(=O)(=O)N(/C(=C(/O)NC2NOC(C2)C)C(=O)C2C1CCCC2)C.

About UNSPSC 51385802

UNSPSC 51385802 Isoxicam, a Commodity code, shows limited direct alignment with recent state and local procurement activity. The nominal pharmaceutical scope does not match the opportunities posted under this code, which instead reflect naloxone procurement, direct-to-manufacturer pharmacy initiatives, and multi-source generic pharmaceuticals and OTC products — none of which are isoxicam-specific solicitations. State and local governments use this code infrequently or misclassify opportunities when they do post them; the recent record does not substantiate ongoing demand for isoxicam itself as a distinct procurement line.

The three opportunities on file span different issuing bodies and procurement phases. Seminole County, Florida released an IFB (IFB60459723LAS) in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year term with renewal option, due July 26, 2023. The Texas Health and Human Services Commission issued an RFI in April 2026 (HHS0017013) to gather vendor capabilities for a direct-to-manufacturer prescription program outside traditional PBM channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, released an RFP in January 2026 (S1070000015802) for generic multi-source pharmaceuticals and OTC products through authorized wholesalers, with proposals due March 26, 2026 and contract effectiveness July 1, 2026. The code shows sparse and scattered activity across Florida, Texas, and Minnesota without evidence of repeated isoxicam-specific demand or a coherent buyer base focused on this commodity.

Quick answers

What is UNSPSC 51385802?

UNSPSC 51385802 is Isoxicam, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51385802?

UNSPSC 51385802 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51385802

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code